Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized neoadjuvant bevacizumab strategies in newly diagnosed locally advanced rectal cancer
2006-003472-35Phase 2Completed
- Sponsor
- Roche
- Start
- Feb 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial of bevacizumab in rectal adenocarcinoma and rectal cancer (2 arms), sponsored by Roche. Started Feb 2007; status: completed.
02
Drugs
bevacizumab
03
Conditions
rectal adenocarcinomarectal cancer
Beyond the preview
Go deeper on 2006-003472-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003472-35.